Evidence map›Paper›PMID 29959141›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Functional Parameters Derived from Magnetic Resonance Imaging Reflect Vascular Morphology in Preclinical Tumors and in Human Liver Metastases.

Pavitra Kannan, Warren W Kretzschmar, Helen Winter, Daniel Warren, Russell Bates, Philip D Allen, Nigar Syed, Benjamin Irving, Bartlomiej W Papiez, Jakob Kaeppler and 11 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05550090 (Clinical Study of Dynamic Contrast-enhanced Magnetic Resonance Imaging Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver Metastasis of Breast Cance), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05550090 unknown statusnot on this mapstarted 2022, after this paper: background citation

Clinical Study of Dynamic Contrast-enhanced Magnetic Resonance Imaging Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver Metastasis of Breast Cance

TypeobservationalSponsorZhejiang Cancer HospitalRan2022 to 2025Enrolled40ConditionsMetastatic Breast Cancer in the LiverArmsChemotherapy
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 2 countries.

Pavitra KannanCRUK and MRC Oxford Institute for Radiation Oncology Department of Oncology, University of Oxford, Oxford, United Kingdom. pk@sciencesylt.com.
Warren W KretzschmarSchool of Engineering Sciences in Chemistry, Biotechnology and Health, Department of Gene Technology, Science for Life Laboratory, KTH Royal Institute of Technology, Stockholm, Sweden.ORCID 0000-0002-2575-0807
Helen WinterCRUK and MRC Oxford Institute for Radiation Oncology Department of Oncology, University of Oxford, Oxford, United Kingdom.
Daniel WarrenCRUK and MRC Oxford Institute for Radiation Oncology Department of Oncology, University of Oxford, Oxford, United Kingdom.ORCID 0000-0001-8025-215X
Russell BatesInstitute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, United Kingdom.
Philip D AllenCRUK and MRC Oxford Institute for Radiation Oncology Department of Oncology, University of Oxford, Oxford, United Kingdom.
Nigar SyedCRUK and MRC Oxford Institute for Radiation Oncology Department of Oncology, University of Oxford, Oxford, United Kingdom.
Benjamin IrvingInstitute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, United Kingdom.
Bartlomiej W PapiezInstitute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-8432-2511
Jakob KaepplerCRUK and MRC Oxford Institute for Radiation Oncology Department of Oncology, University of Oxford, Oxford, United Kingdom.
Bosjtan MarkelcCRUK and MRC Oxford Institute for Radiation Oncology Department of Oncology, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-8674-702X
Paul KincheshCRUK and MRC Oxford Institute for Radiation Oncology Department of Oncology, University of Oxford, Oxford, United Kingdom.
Stuart GilchristCRUK and MRC Oxford Institute for Radiation Oncology Department of Oncology, University of Oxford, Oxford, United Kingdom.
Sean SmartCRUK and MRC Oxford Institute for Radiation Oncology Department of Oncology, University of Oxford, Oxford, United Kingdom.
Julia A SchnabelInstitute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, United Kingdom.ORCID 0000-0001-6107-3009
Tim MaughanCRUK and MRC Oxford Institute for Radiation Oncology Department of Oncology, University of Oxford, Oxford, United Kingdom.
Adrian L HarrisCRUK and MRC Oxford Institute for Radiation Oncology Department of Oncology, University of Oxford, Oxford, United Kingdom.
Ruth J MuschelCRUK and MRC Oxford Institute for Radiation Oncology Department of Oncology, University of Oxford, Oxford, United Kingdom.
Mike PartridgeCRUK and MRC Oxford Institute for Radiation Oncology Department of Oncology, University of Oxford, Oxford, United Kingdom.
Ricky A SharmaCRUK and MRC Oxford Institute for Radiation Oncology Department of Oncology, University of Oxford, Oxford, United Kingdom.
Veerle KersemansCRUK and MRC Oxford Institute for Radiation Oncology Department of Oncology, University of Oxford, Oxford, United Kingdom.
CRUK/MRC Oxford Institute for Radiation Oncology · GBScience Oxford · GBChurchill Hospital · GBKing's College London · GBKTH Royal Institute of Technology · SE

Funding

Cancer Research UK 16466Cancer Research UK 18974Cancer Research UK 20407Cancer Research UK 8971
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Magnetic Resonance ImagingAgedAngiogenesis InhibitorsAnimalsAntibodies, Anti-IdiotypicCell Line, TumorColorectal NeoplasmsContrast MediaHumansLiver NeoplasmsMaleMiceMiddle AgedNeovascularization, PathologicVascular Endothelial Growth Factor Receptor-2Angiogenesis InhibitorsAntibodies, Anti-IdiotypicContrast MediaKDR protein, humanVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID29959141
PMCPMC6171743
OpenAlexW2810997680

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.